10 BANK STREET, SUITE 560, WHITE PLAINS, NY
Announces Annual General Meeting
Announces FDA Approval of saypha® ChIQ™ Injectable Hyaluronic Acid Gel
Announces Conclusion of SEC Investigation
Reports Q4 2025 and FY 2025 Financial Results
Announces Fourth Quarter and Fiscal Year 2025 Earnings Date
Announces Annual Meeting of Shareholders Results
Material disclosure
Annual and Transition Report of Foreign Private Issuers
Amended Annual and Transition Report of Foreign Private Issuers
Effectiveness Notice
Prospectus filed pursuant to Rule 424(b)(3)
Registration Statement for Securities of Certain Foreign Private Issuers and Certain Canadian Issuers, Offered on a Continuous Basis
No filings found
Amended Schedule 13D - Ownership Report
Amended Schedule 13G - Ownership Report
Initial Statement of Beneficial Ownership
Submission Upload
Correspondence